All Articles

New Phase 2a data reveals Oruka Therapeutics' ORKA-001 achieved complete skin clearance in nearly two-thirds of patients, positioning it as a potential game-changer.

Nakheel awards massive contracts for 544 luxury villas on Palm Jebel Ali, marking a major step in the revival of one of Dubai's most ambitious projects.

With new global-flavor kits and celebrity chef Antoni Porowski, Fresh Express aims to transform the humble salad from a simple side to a main course.

An upcoming summit highlights how AI is shifting workplace safety from reaction to prediction, but implementing this powerful technology comes with challenges.

As AI and nuclear power drive demand, a new project in Saskatchewan promises a faster, cheaper uranium supply. But can it deliver on its ambitious goals?

Global design firm Populous brings back veteran architect Loren Supp to spearhead innovation in its Western U.S. offices, signaling a new tech-driven era.

A new report reveals payers are rewriting drug benefit rules, sacrificing rebates for more control as they grapple with the high cost of new therapies.

Wealth intelligence platform Masttro hires Dan Gorlick as CPO, signaling a major push in AI and global expansion for the ultra-high-net-worth market.

Moving beyond dashboards, IntegriChain's new conversational AI promises trusted, auditable insights to navigate biopharma's complex commercial landscape.

Tecnau and Standard Finishing Systems announce a partnership to boost efficiency and flexibility for high-volume printers across North America.

Renowned inventor Dr. Yuan Gao's board appointment signals a major push for Pure Lithium’s disruptive, cobalt-free battery technology and its bold strategy.

With investments exceeding $1B, PCI Pharma Services is expanding its US sterile manufacturing, tackling supply chain risks and boosting domestic production.

The Sterling Group's acquisition of The Scruggs Companies signals a major private equity push into America's vital and aging water infrastructure sector.

A UK firm's breakthrough blood test for early breast cancer detection joins a prestigious EU network, aiming to personalize treatment and redefine diagnostics.

A new ownership group acquires iconic Ghirardelli Square, signaling a major vote of confidence in SF's economic revival and a new vision for the landmark.

Diagnostics firm QuantiPath adds Roger Schaller, a veteran of high-profile exits, to its board, signaling a strategic push for its advanced food safety tech.

With its AI-powered blood test nearing FDA review, DELFI Diagnostics adds a top biotech CFO to its board, signaling major commercial and IPO ambitions.

Once a student finding refuge at Milton Hershey School, Maria Trinh Kraus now chairs its boards, shaping the very legacy that transformed her own life.

With a Series A led by Pantera Capital, the Seoul-based firm is pivoting to provide full-stack infrastructure as institutional adoption accelerates in Asia.

The sale of Parkdale Center highlights private equity's growing appetite for specialized mental healthcare and marks a strategic entry into Indiana's strained market.